LUTS: A Risk Factor for Sexual Dysfunction in the BPH Patient

By Moncada I.  

European Urology Supplements, Vol. 2, Iss. 10, 2003-12 ,pp. : 3-8

Elsevier

Access to resources Recommend Favorite

LUTS and Sexual Dysfunction: Implications for Management of BPH

By van Moorselaar J.  

European Urology Supplements, Vol. 2, Iss. 10, 2003-12 ,pp. : 13-20

Elsevier

Access to resources Recommend Favorite

Long-Term Safety and Efficacy of a Once-Daily Formulation of Alfuzosin 10 mg in Patients with Symptomatic Benign Prostatic Hyperplasia: Open-Label Extension Study

By van Kerrebroeck P.   Jardin A.   van Cangh P.   Laval K.U.   The ALFORTI Study Group  

European Urology, Vol. 41, Iss. 1, 2002-01 ,pp. : 54-61

Elsevier

Access to resources Recommend Favorite

First dose efficacy of alfuzosin once daily in men with symptomatic benign prostatic hyperplasia

By Marks L.S.   Roehrborn C.G.   Gittelman M.   Kim D.   Forrest J.   Jacobs S.  

Urology, Vol. 62, Iss. 5, 2003-11 ,pp. : 888-893

Elsevier

Access to resources Recommend Favorite

Impact of low urinary tract symptoms (LUTS) on sexual function in urological patients

By Korneyev L.A.   Kozlov   Al-Shukri  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 118-118

Elsevier

Access to resources Recommend Favorite